MAPT and early-onset autosomal dominant Alzheimer disease: The Alzheimer’s disease related MAP, tau (MAPT), is highly enriched in neuronal axons and inhibits kinesin-1 motility in vivo and in vitro, but has less of an effect on dynein-based movement3,7–11.